Tag: ASX:CURE

Learn More FREE TRIAL

S&P Biotech ETF

Posted on April 23, 2025 | by Leon Hinde | Leave a Comment

Global X S&P Biotech is rated a buy with the stop loss at $40.08

S&P Biotech ETF

Posted on February 28, 2025 | by Leon Hinde | Leave a Comment

Global X S&P Biotech is under Algo Engine buy conditions.

Cure ETF

Posted on January 22, 2025 | by Leon Hinde | Leave a Comment

Global X S&P Biotech is rated a buy at $49.03

S&P Biotech

Posted on November 20, 2024 | by Leon Hinde | Leave a Comment

Global X S&P Biotech is under Algo Engine buy conditions.

S&P Biotech ETF

Posted on November 7, 2024 | by Leon Hinde | Leave a Comment

Global X S&P Biotech is under Algo Engine buy conditions.

S&P Biotech ETF

Posted on October 30, 2024 | by Leon Hinde | Leave a Comment

Global X S&P Biotech is under algo engine buy conditions, and the higher low support has increased to $49.60

Biotech ETF

Posted on October 14, 2024 | by Leon Hinde | Leave a Comment

Global X S&P Biotech is rated a buy with a stop loss of $48.55

Biotech ETF

Posted on June 24, 2024 | by Leon Hinde | Leave a Comment

Global X S&P Biotech has a higher low formation with support at $45.

CURE ETF

Posted on May 2, 2024 | by Leon Hinde | Leave a Comment

Global X S&P Biotech is trending higher after creating the $42.50 pivot low.

Global Biotech ETF

Posted on April 29, 2024 | by Leon Hinde | Leave a Comment

Global X S&P Biotech

Send our ASX Research to your Inbox

Or start a free thirty day trial for our full service, which includes our ASX Research.